On the basis of differentially expressed genes (DEGs) identified through the Gene Expression Omnibus (GEO) portal, it was found that elevated NEK2 gene expression was linked to drug resistance in ovarian cancer, compared to the parental counterparts [3]. This evidence concerns the gene NEK2 and ovarian cancer.